DF/HCC Kidney Cancer Symposium Abstract and Poster Request
JANUARY 19, 2017
We invite all DF/HCC renal cancer and/or cancer metabolism researchers to attend the symposium and particularly want to encourage Fellows, Residents, Post-docs, and Junior Faculty, as well as minorities and women, to submit abstracts.
Abstracts (plus posters) are being accepted in the following four categories:
- cancer metabolism
- cell biology and signaling
- clinical/translational studies
- genetics and genomics
The abstract should feature recent findings that are unpublished at the time of submission or were published no earlier than January 2017. It will be acceptable to include findings and posters that have been submitted to AACR and/or ASCO conferences. The abstracts will be reviewed by the members of the DF/HCC Kidney Cancer Program, and the authors of the four “best abstracts” will be invited to present their findings at the symposium and will be awarded a cash prize. The deadline for abstract submission is January 24th 2017. Please submit the abstract by email to David McDermott, MD (BIDMC) at: firstname.lastname@example.org, and Tara Johnston at: email@example.com
ABSTRACT REQUIREMENTS: Abstracts must be 500 words or less, and fit on an 8 1⁄2 x 11” paper with 1” margins on all sides. Include the title and authors at the top and acknowledgments at the bottom. You may have one (1) figure or one (1) table, and these illustrations must fit on the same page as the abstract text. In addition, please prepare a color poster (size TBD, will advise later - related to the abstract) for exhibition at the symposium. The posters should be brought to the symposium on March 3rd, 2017 by 8a. They will be discussed and reviewed during the day’s poster session.
Advance registration will be required in order to attend the symposium. An email announcement will be sent in December 2017 requesting RSVPs. In the meantime please save the date and send this call-for-abstracts to colleagues, trainees, students, fellows, residents and young faculty.
DF/HCC Kidney Cancer Program leadership:
David McDermott, MD (BIDMC)
Toni Choueiri, MD (DFCI)
Othon Iliopoulos, MD (MGH)
William Kaelin, MD (DFCI)
Marc Dror Michaelson, MD, PhD (MGH)
Sabina Signoretti, MD (BWH)